SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 19, 2004 PHARMOS CORPORATION (Exact name of Registrant as Specified in its Charter) Nevada 0-11550 36-3207413 (State or Other Jurisdiction (Commission file Number) (IRS Employer of Incorporation) Identification No.) 99 Wood Avenue South, Suite 311, Iselin, New Jersey 08830 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (732) 452-9556 Item 5. Other Events On July 19, 2004, Pharmos Corporation ("Pharmos") issued a press release announcing the appointment of James A. Meer as Vice President, Chief Financial Officer, Secretary and Treasurer. A copy of Pharmos' press release is attached as Exhibit 99.1 and is incorporated herein by reference. Item 7. Financial Statements and Exhibits (c) Exhibits. 99.1 Press Release dated July 19, 2004. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 20th day of July, 2004. PHARMOS CORPORATION By: /s/ Haim Aviv ------------------------------ Name: Haim Aviv Title: Chairman of the Board, Chief Executive Officer